The TIL-based therapy market is projected to grow at an annualized rate of 40%, claims Roots Analysis
Owing to their tumor-killing capability and therapeutic superiority to conventional therapies, TIL-based therapies are being actively evaluated to treat advance, incurable oncological disorders by various researchers and industry stakeholders. Partnership activity within this domain has grown at a CAGR of 29%, between 2015 and 2021 Majority of the agreements related to TIL-based therapies were...
0 Commentaires 0 Parts 1310 Vue 0 Aperçu
Commandité